The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Absence of CD4+ and CD8+ T cell expansion after primary multimodal treatment predicts early progression in inoperable stage III NSCLC.
 
Thomas Philipp Hofer
No Relationships to Disclose
 
Alexander Nieto
No Relationships to Disclose
 
Lukas Käsmann
No Relationships to Disclose
 
Julian Taugner
No Relationships to Disclose
 
Carolyn Pelikan
No Relationships to Disclose
 
Dinar Katanov
No Relationships to Disclose
 
Chukwuka Eze
No Relationships to Disclose
 
Julian Guggenberger
No Relationships to Disclose
 
Claus Belka
Honoraria - AstraZeneca/MedImmune; Bristol-Myers Squibb; C-RAD; Elekta; Merck; MSD; Novartis; opasca; Roche; ViewRay
Consulting or Advisory Role - AstraZeneca/MedImmune; Elekta; Merck; MSD; Novartis
Research Funding - Merck; MSD; Roche
 
Elfriede Noessner
Honoraria - AstraZeneca/MedImmune; Hexal; Ipsen; Roche
Consulting or Advisory Role - Definiens; Visiopharm
Research Funding - Phio Pharmaceuticals
Patents, Royalties, Other Intellectual Property - Medigene
 
Farkhad Manapov
Honoraria - AstraZeneca; BrainLAB; Elekta
Consulting or Advisory Role - AstraZeneca
Speakers' Bureau - Elekta
Research Funding - AstraZeneca